<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:npr="https://www.npr.org/rss/" xmlns:nprml="https://api.npr.org/nprml" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>NPR: thalidomide</title>
    <link>https://www.npr.org/templates/story/story.php?storyId=160394783</link>
    <description>thalidomide</description>
    <language>en</language>
    <copyright>Copyright 2024 NPR - For Personal Use Only</copyright>
    <generator>Story API Shim 1.2.24</generator>
    <lastBuildDate>Tue, 27 May 2025 20:28:22 -0400</lastBuildDate>
    <image>
      <url>https://media.npr.org/images/podcasts/primary/npr_generic_image_300.jpg?s=200</url>
      <title>NPR: thalidomide</title>
      <link>https://www.npr.org/tags/160394783/thalidomide</link>
    </image>
    <item>
      <title>Protect Pregnant Women &apos;Through Research,&apos; Not &apos;From Research,&apos; OB-GYNs Urge</title>
      <description>As COVID-19 vaccines roll out, doctors say it&apos;s long past time to address the exclusion of pregnant women from research on drugs and vaccines. They say better study design is the answer.</description>
      <pubDate>Mon, 25 Jan 2021 05:00:00 -0500</pubDate>
      <link>https://www.npr.org/sections/health-shots/2021/01/25/958862775/protect-pregnant-women-through-research-not-from-research-ob-gyns-urge</link>
      <guid>https://www.npr.org/sections/health-shots/2021/01/25/958862775/protect-pregnant-women-through-research-not-from-research-ob-gyns-urge</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2021/01/20/gettyimages-1224350800-e5ab912af09227829717003e52163ad80f571c95.jpg' alt='According to a review published in 2018, nearly 75% of the drugs approved by the Food and Drug Administration in the 21st century had no data associated with their use during pregnancy.'/><p>As COVID-19 vaccines roll out, doctors say it's long past time to address the exclusion of pregnant women from research on drugs and vaccines. They say better study design is the answer.</p><p>(Image credit: Orbon Alija)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=958862775' />]]></content:encoded>
      <dc:creator>Maggie Mertens</dc:creator>
    </item>
    <item>
      <title>Frances Kelsey, FDA Officer Who Blocked Thalidomide, Dies At 101</title>
      <description>The physician and pharmacologist worked at the government agency in the early 1960s, when she uncovered a link between the drug and severe birth defects.</description>
      <pubDate>Sat, 08 Aug 2015 13:20:00 -0400</pubDate>
      <link>https://www.npr.org/sections/thetwo-way/2015/08/08/430709628/frances-kelsey-fda-officer-who-blocked-thalidomide-dies-at-101</link>
      <guid>https://www.npr.org/sections/thetwo-way/2015/08/08/430709628/frances-kelsey-fda-officer-who-blocked-thalidomide-dies-at-101</guid>
      <content:encoded><![CDATA[<p>The physician and pharmacologist worked at the government agency in the early 1960s, when she uncovered a link between the drug and severe birth defects.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=430709628' />]]></content:encoded>
      <dc:creator>Scott Neuman</dc:creator>
    </item>
    <item>
      <title>Thalidomide Maker Apologizes After More Than 50 Years</title>
      <description>More than a half-century after a German drugmaker took thalidomide off the market because of birth defects, the company said it was sorry. The occasion was the dedication of a memorial to the victims near the company&apos;s headquarters. The sculpture features a girl with malformed feet and no arms.</description>
      <pubDate>Fri, 31 Aug 2012 16:27:00 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2012/08/31/160391482/maker-of-thalidomide-apologizes-after-more-than-50-years</link>
      <guid>https://www.npr.org/sections/health-shots/2012/08/31/160391482/maker-of-thalidomide-apologizes-after-more-than-50-years</guid>
      <content:encoded><![CDATA[<p>More than a half-century after a German drugmaker took thalidomide off the market because of birth defects, the company said it was sorry. The occasion was the dedication of a memorial to the victims near the company's headquarters. The sculpture features a girl with malformed feet and no arms.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=160391482' />]]></content:encoded>
      <dc:creator>Scott Hensley</dc:creator>
    </item>
  </channel>
</rss>